Skip to main content
SpringerLink
Log in
Book cover

Das Harnblasenkarzinom pp 195–208Cite as

Urin-Marker beim Harnblasenkarzinom: Stellenwert der Urinenzymdiagnostik

  • Chapter

  • 29 Accesses

Zusammenfassung

Dem Anliegen, mit Hilfe der Urindiagnostik Hinweise auf Frühstadien des Harnblasenkarzinoms zu erhalten, wurde umfassend durch Verbesserung und Vereinfachung der Urinzytologie Rechnung getragen. Über diese Technik hinaus besteht jedoch Interesse an labordiagnostisch erfaßbaren Frühindikatoren dieses Tumors.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Aeikens B (1981) Histochemische Untersuchungen an menschlichen Hamblasentumoren. Urol Int 36: 152–157

    Article  PubMed  CAS  Google Scholar 

  • Belfiori F, Vecchio LL, Napoli E, Borzi V (1974) Increased beta-N-acetyl-glucosaminidase activity in diabetes mellitus. Clin Chem 20: 1229–1230

    Google Scholar 

  • Boyland E, Wallace DM, Williams DC (1955) The activity of the enzymes sulphatase and beta glucuronidase in the urine, serum and bladder tissue. Br J Cancer 9: 62–79

    Article  PubMed  CAS  Google Scholar 

  • Carr AJ (1963) Effect of some glycosidase inhibitors on experimental tumours in the mouse. Nature 198: 1104–1105

    Article  PubMed  CAS  Google Scholar 

  • Can AJ, Steyn JM (1972) Glycolytic enzyme activity in bladder tomours. S Afr Med J 46: 48–50

    Google Scholar 

  • Drahovsky D, Winkler A, Skoda J (1964) Increased urinary pseudouridine excretion following irradiation. Nature 201: 411–413

    Article  PubMed  CAS  Google Scholar 

  • Drahovsky D, Winkler A, Skoda J (1965) Urinary excretion of pseudouridine in the course of x-ray therapy. Neoplasma 12: 561–564

    PubMed  CAS  Google Scholar 

  • Droller MJ (1976) Differences in adenylate cyclase activities in murine normal cells and bladder tumor cells in tissue culture. Invest Urol 14: 249–252

    PubMed  CAS  Google Scholar 

  • Dunzendorfer U, Katopodis N, Dnistrian AM, Stock CC, Schwartz MK, Whitmore WF jr (1981) Plasma lipid bound sialic acid in patients with prostate and bladder cancer. Invest Urol 19: 194–196

    PubMed  CAS  Google Scholar 

  • El-Aaser AA, El-Merzabani MM, Higgy NA, Kader MMA ( 1977 a) A study on the aetiological factors of bilharzial bladder cancer in egypt. 3. Urinary beta-Glucuronidase. Eur J Cancer 15: 573–583

    Google Scholar 

  • El-Sewedy SM, Arafa A, Abdel-Aal G, Mostafa MH (1979) The activities of urinary alphaesterases in bilharziasis and their possible role in the diagnosis of bilharzial bladder cancer in egypt. Trans R Soc Med Hyg 72: 525–528

    Article  Google Scholar 

  • Fujinaga T, Nakamura J, Sangen H, Okhawa T, Kido R (1980) A new method to determine urinary aninoline compounds in patients with bladder cancer. Invest Urol 17: 416–418

    PubMed  CAS  Google Scholar 

  • Goedde HW, Brunched H (1965) Beta-Aminosobutyric acid: a thin-layer chromatographic method for the quantitative estimation in human urine. Clin Chim Acta 11: 485–490

    Article  PubMed  CAS  Google Scholar 

  • Gorrod JW (1967) The interaction of aromatic amines and some hydroxylated derivatives with cellular processes. In: Deichmann W (ed) Bladder cancer. Aesculap Publishing 6 Birmingham Alabama, p 107–121

    Google Scholar 

  • Guthrie D, Isah H, Latner GA (1979) Urine cyclic GMP: a possible biochemical marker for cancer. IRCS Med Sci 7: 209

    CAS  Google Scholar 

  • Hennessey PT, Hurst RE, Hemstreet GP, Cutter G (1981) Urinary glycosaminoglycan excretion as a biochemical marker in patients with bladder carcinoma. Cancer Res 41: 3868–3873

    PubMed  CAS  Google Scholar 

  • Hurst RE, Hemstreet GP, Hennessey PT (1981) Abnormal urinary glycosaminoglycan excretion in bladder carcinoma. Am Urol Ass 76: 112

    Google Scholar 

  • Ichikawa T, The Japan Research Group of bladder cancer (1972) Clinical application of 2,5Di-o-Acetyl-beta-D-Glucaro-(1–4)-(6–3)-Dilactone ( SLA) to the bladder tumor with special reference to its effect on frequency of tumor recurrences. J Urol 108: 571–576

    Google Scholar 

  • Irving ChC (1977) Biochemically detectable tumor markers in Urine of bladder cancer patients. Cancer Res 37: 2872–2874

    PubMed  CAS  Google Scholar 

  • Jüngst D, Pickel A, Stadler A, Marx FJ, Elsässer E, Karl HJ (1979) Comparative evaluation of nonesterified and total urinary cholesterol in papilloma and carcinoma of the bladder. Cancer 43: 2486–2491

    Article  PubMed  Google Scholar 

  • Korosteleva TA, Kliucharev BV, Benteleva TA (1979) 3-Hydroxyanthranilic acid content in the urine of bladder cancer patients. Vopr Onkol 25: 36–39

    Google Scholar 

  • Kunze E, Schauer A (1971) Enzymhistochemische and autoradiographische Untersuchungen an Dibutylnitrosamin-induzierten Hamblasenpapillomen der Ratte. Z Krebsforsch 75: 146–160

    Article  PubMed  CAS  Google Scholar 

  • Lower GM, Nilsson T, Nelson CE, Wolf H, Gamsky TE, Bryan GT (1979) N-Acetyltransferase phenotype and risk in urinary bladder cancer: Approaches in molecular epidemiology. Preliminary results in sweden and denmark. Environ Health Perspect 29: 71–79

    Article  PubMed  CAS  Google Scholar 

  • Maruhn D (1976) Rapid colorimetric assay of beta-galactosidase and N-acetyl-beta-glucosaminidase in human urine. Clin Chim Acta 73: 453–461

    Article  PubMed  CAS  Google Scholar 

  • Mc Gregor RF, Crawford R, Johnson DE, Brown B, Sharon MS, Johnston D (1977) Urinary amino-acid excretion. Comparison of normal individuals and patients with bladder cancer. Urology 9: 538–542

    Article  CAS  Google Scholar 

  • Motomiya Y, Yamada K, Matsushima S, Jjyuin M, Jriya K, Okajima E (1975) Studies on urinary isoenzymes of lactic dehydrogenase and beta-Glucuronidase in patients with bladder tumors. Urol Res 3: 41–48

    Article  PubMed  CAS  Google Scholar 

  • Nielsen HR, Nyholm K, Sjölin K-E (1974) Relationship between urinary beta-Aminoisobutyric acid and transfer-RNA turnover in cancer patients. Cancer Res 34: 3428–3432

    PubMed  CAS  Google Scholar 

  • Nyholm KK, Sjölin K-E, Hammer M, Knudsen J, Stahl D, Nielsen FIR (1975) A study on the clinical significance of urinary beta-Aminoisobutyric acid in patients with urothelial tumours. Biomedicine 22: 509–516

    PubMed  CAS  Google Scholar 

  • O’Brien P, Gozzo JJ, Monaco AP (1980) Urinary proteins as biological markers: bladder cancer diagnosis versus urinary tract infection. J Urol 124: 802–803

    PubMed  Google Scholar 

  • Paigen B, Ward E, Steenland K, Havens M, Sartori P (1979) Aryl hydrocarbon hydroxylase inducibility is not altered in bladder cancer patients or their progeny. Int J Cancer 23: 312–315

    Article  PubMed  CAS  Google Scholar 

  • Pastorini P, Milano G, Toubol J, Raymond G, Cambon P, Lalanne CM (1981) The diagnostic and prognostic value of urinary polyamine measurement in bladder cancer. Urol Res 9: 13–16

    Article  PubMed  CAS  Google Scholar 

  • Plotkin GM, Wides RJ, Gilbert SL, Wolf G, Hagen JK, Prout GR (1979) Galactosyl transferase activity in human transitional cell carcinoma lines and in benign and neoplastic human bladder epithelium. Cancer Res 39: 3856–3860

    PubMed  CAS  Google Scholar 

  • Posey LE, Morgan LR (1977) Urine enzyme activities in patients with transitional cell carcinoma of the bladder. Clin Chim Acta 74: 7–10

    Article  PubMed  CAS  Google Scholar 

  • Reutter W (1979) Testung von Serum-Glycosyltransferasen von Tumorpatienten vor and im Verlauf der Behandlung. Projekt-Status Bericht DFVLR: 309

    Google Scholar 

  • Sanford EJ, Drago JR, Rohner TJ, Kessler GF, Sheehan L, Lipton A (1975) Preliminary evaluation of urinary polyamines in the diagnosis of genitourinary tract malignancy. J Urol 113: 218–221

    PubMed  CAS  Google Scholar 

  • Sufrin G, Tritsch GL, Mittelman A, Murphy GP (1978) Studies of lymphocyte adenosine deaminase activity in patients with renal and transitional cell carcinoma. Int Adv Surg Oncol 1: 11–28

    PubMed  CAS  Google Scholar 

  • Tanaka K (1977) Beta-Glucuronidase in patients with bladder carcinoma. Acta Urol Jpn 23: 557–565

    Google Scholar 

  • Waalkes TPh, Gehrke ChW, Lakings DB, Zumwalt RW, Kuo KC, Jacobs SA, Borek E (1976) Beta-Aminoaciduria in patients with Burkitt’s Lymphoma. J Natl Cancer Inst 57: 435–438

    PubMed  CAS  Google Scholar 

  • Wajsman Z, Williams PD, Greco J, Murphy GP (1978) Further study of fibrinogen degradation products in bladder cancer detection. Urology 12: 659–661

    Article  PubMed  CAS  Google Scholar 

  • Wellwood JM, Ellis BG, Hall JH, Robinson DR, Thompson AE (1973) Early warning of rejection? Br Med J 2: 261–265

    Article  PubMed  CAS  Google Scholar 

  • Wellwood JM, Ellis BG, Price RG, Hammond K, Thompson AE, Jones NF (1975) Urinary N-acetyl-beta-D-Glucosaminidase activities in patients with renal disease. Br Med J 3: 408–411

    Article  PubMed  CAS  Google Scholar 

  • Williams DR, Cartwright RA (1978) The esterase-D polymorphism in patients with diabetes or carcinoma of the bladder and a matched sample of non-donor controls. Ann Hum Biol 5: 281–284

    Article  PubMed  CAS  Google Scholar 

  • Wirl G, Frick J (1979) Collagenase–a Marker enzyme in human bladder cancer? Urol Res 7: 103–108

    Article  PubMed  CAS  Google Scholar 

  • Young SE, Griffin AC, Milner AN, Stehlin JS (1967) Free aminoacids and related compounds in the blood and urine of patients with malignant melanoma. Cancer Res 27: 15–17

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Urologie, Eberhard-Karls-Universität Tübingen, Calwer Straße 7, D-7400, Tübingen, Deutschland

    R. Harzmann & K.-H. Bichler

  2. Hoechst AG, D-6230, Frankfurt/Hoechst, Deutschland

    D. Gericke & H. Groetsch

Authors
  1. R. Harzmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Gericke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Groetsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. K.-H. Bichler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Urologie, Eberhard-Karls-Universität Tübingen, Calwer Straße 7, D-7400, Tübingen 1, Deutschland

    Karl-Horst Bichler (Lehrstuhl) & Rolf Harzmann (Lehrstuhl) & 

Rights and permissions

Reprints and permissions

Copyright information

© 1984 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Harzmann, R., Gericke, D., Groetsch, H., Bichler, KH. (1984). Urin-Marker beim Harnblasenkarzinom: Stellenwert der Urinenzymdiagnostik. In: Bichler, KH., Harzmann, R. (eds) Das Harnblasenkarzinom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69535-3_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-69535-3_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-69536-0

  • Online ISBN: 978-3-642-69535-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation